Actively Recruiting
Study of Lacripep Eye Drops for Healing Corneal Wounds After Laser Eye Surgery in Military Members and Dependents
Led by Henry M. Jackson Foundation for the Advancement of Military Medicine · Updated on 2026-03-25
88
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the safety and effectiveness of Lacripep, an investigational eyedrop medication, for repairing superficial corneal injuries such as those caused by Photorefractive keratectomy PRK, eye trauma, or surgery. This study focuses on active-duty military service members and their dependents to understand if Lacripep can help heal the corneal surface and speed up visual recovery after injury. Participants will receive Lacripep in one eye and a placebo in the other eye simultaneously after undergoing bilateral PRK surgery. The study will follow participants for six months postoperatively to assess the medications effects on corneal healing and ocular surface health. During the study, participants will have their corneal epithelial thickness measured at 4 and 7 days after surgery, then again at 1, 3, and 6 months. Safety monitoring will occur from enrollment through the six-month treatment period. Participants must be able to attend follow-up visits and will be monitored for both healing progress and any side effects related to the treatment.
CONDITIONS
Brief Title
Lacripep for Corneal Wound Healing Study
Research Team
Z
Zachary P Skurski, DO
R
Rose Sia
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
